Hypothesis. Aldosterone has direct or indirect effects on atherosclerosis, and polymorphisms occur in the gene encoding aldosterone synthase (CYP11B2), the enzyme catalysing aldosterone biosynthesis. Genetic variations in aldosterone synthesis may influence progression of carotid atherosclerosis. Materials and methods. Ten subjects were genotyped through the use of the polymerase chain reaction for two diallelic polymorphisms in CYP11B2: one in the transcriptional regulatory region (promotor) and the other in the second intron. In vivo plaque size was estimated by H-1 magnetic resonance imaging using gradient echo pulse sequence. Mediaintima thickness and ex vivo plaque in endarterectomy samples were measured by histology. Matrix metalloprotease (MMP)-9 was stained in endarterectomy histology sections and apoptosis index was counted in these sections. Results. The CYP11B2 promoter genotype patterns were associated significantly with the plaque size in carotid artery (r 2 =0.9987; p=0.001), MMP-9 levels (r 2 =0.9878; p=0.0001) and apoptotic indices (r 2 =0.9495; p=0.005) by multiple regression analysis. The media-intima thickness was not significantly correlated with genotype patterns. Conclusion. Genetic variations in aldosterone synthase (CYP11B2) gene are associated with the progression of atherosclerotic plaque size, MMP-9 and apoptosis in the carotid artery.
Introduction
Renal-vascular hypertension, arterial hypertension and high aldosterone-renin hypertension are all associated with an excess prevalence of carotid artery atherosclerotic lesions with a higher risk of stroke. 1, 2 To date, evidence does not exist to show the associated link between the activation of the renin-angiotensin-aldosterone system (RAAS) with accelerated carotid atherosclerosis and the subject remains controversial. Aldosterone hormone activity (primary aldosteronism) is probably gene regulated and appears to be accompanied by a high prevalence of carotid artery lesions. To verify this hypothesis, we correlated plaque size by in vivo magnetic resonance images, carotid artery lesions, matrix metalloprotease (MMP)-9 and apoptosis indices to try and establish an association with the aldosterone synthase gene.
Aldosterone controls sodium balance, and affects intravascular lipids and blood pressure. Therefore, genetic variations in the regulation of aldosterone synthesis might influence the atherosclerosis plaque development, vascular metalloprotease and cell proliferation in carotid arteries. Aldosterone secretion is regulated by the renin-angiotensin system, while aldosterone synthesis from deoxycorticos terone is regulated by the aldosterone synthase (CYP11B2) gene located on chromosome 8, band 8q22. 3 Aldosterone synthase enzyme and plasma aldosterone levels in individuals with essential hypertension are implicated in the pathogenesis of carotid artery atherosclerosis. 4, 5 Aldosterone has a variety of actions such as induction of gene expression, and promotion of cell proliferation, apoptosis and oxidation of lowdensity lipoprotein. These intracellular changes are considered to be involved in the initiation and progression of carotid atherosclerosis with measurable changes in carotid wall thickness and MMP enzymes, and magnetic resonance imaging (MRI)-visible and measurable changes in lipid deposits in the media. In the present study, an association was demonstrated between CYP11B2 gene variations and polymorphism patterns with carotid atherosclerosis media-intima thickness, plaque size, MMP-9 enzyme activity and apoptosis indices. This information has Preliminary studies on human aldosterone synthase (CYP11B2) gene polymorphism, matrix metalloprotease-9, apoptosis, and carotid atherosclerosis plaque size by proton magnetic resonance imaging the potential of generating a useful non-invasive MRI tool to indicate gene polymorphism and rapid quantitative assessment of disease with improved diagnosis.
Materials and methods
Patients showing occlusive carotid atherosclerosis with lumen stenosis 40% or more underwent endarterectomy. The patients had a long history of hypertension. The patients were on statin therapy, beta blocker/diuretic therapy, angiotensinconverting enzyme inhibitors and were excluded with valvulopathy and cardiac diseases. Laboratory data showed hyperlipidaemia including cholesterol-C, TG and LDL-C and low HDL-C.
The aldosterone synthase gene from samples was amplified by polymerase chain reaction using Taq polymerase and specific nucleotides for amplification at a preset temperature cycle of annealing and synthesis. The amplified product was genotyped for segments of the CYP11B2 gene (DNA) using nucleotide sequencing similar to methods described elsewhere for blood samples. 3 The electrophoresis was performed by sampling 0.01-ml samples in a 14-well vertical chamber.
For MMP-9 enzyme localisation, 3-mm long carotid tissues were soaked in buffer at 20°C for 2 hours to release MMP-9. MMP-9 immunostaining was performed using biotinylated-MMP inhibitor to zymo-graphically label MMP-9 in the regions of mononuclear cell accumulation in the carotid plaque. 5, 6 The zymography (electrophoresis for zymograms) was performed in 10% gels containing gelatin on carotid artery tissue segments. Gels were stained with 30% Coomassie blue dye 5 . Bands were visualized by Image J to get MMP-9 bands (data is not presented here). The immuno-blank sections were used to do immunostaining of MMP in conjunction with zymography. Different histology sections with MMP distribution visualized the spatial localization of MMP in different segments of carotid artery endarterectomy as described in reference 6 . For histopathology immunostaining, the biotinylated anti-MMP-9 complex as band digital density at each segment was fused at corresponding carotid artery MRI segment images to make a co-registered fusion digital MMP-9 image using Image J feature color coding in RGB set with color range 1 (minimum MMP-9 intensity) and 255(maximum MMP-9 intensity). Different histology sections with MMP-9 distribution visualized the spatial localization of MMP in different segments of carotid artery endarterectomy samples. The immunoblank sections were used to do immunostaining of MMP-9. Different histology sections with MMP-9 distribution visualized the spatial localization of MMP in different segments of carotid artery endarterectomy as described in reference 6 In histology sections of excised endarterectomy specimens, media-intima thickness was measured by averaging the difference of outer radius Carotid artery narrowing with time. One-to-three-month period is shown in MRI images (panels on top with arrow), and gradientecho, spin-echo, T1-w and T2-w images are shown (panels on lower left) for location of common carotid artery and branches. The power of MRI is represented for carotid wall thickness and its comparison with a normal artery (lower rightmost panel). -inner radius (in mm) at six locations at different angles 60°, 120°, 180°, 240°, 300° and 360° clockwise, as described elsewhere. 5, 6, 17, 18 For in vivo MR studies, a GE Horizon LX system equipped with a bilateral 2-coil phase array (6 cm, UltraImage) was used to acquire PDW, T1W (with option of fat saturation) and T2W images centred at the carotid bifurcation. 8, 15 Inferior and superior spatial saturation bands were applied to decrease the intravascular flowing protons and an oblique saturation band was applied to decrease a strong fat signal. Peripheral cardiac gating with digital oximetry sensor was used to limit motion artifacts. For wall measurements, eFILM software was used. 9, [11] [12] [13] Apoptosis indices were measured in tissue sections using an anti-single strand-DNA monoclonal antibody method of single strand DNA (ss-DNA), as described elsewhere (Chemicon International, CA, USA). 19 
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Statistical analysis
The digital histology images, immunoassaying images and MRI images were co-registered using fiduciary markers. 5 The correlation analysis was performed by multivariate correlation for association between CYP11B2 gene promoters (T, C alleles; TT, CT and CC genotypes) with plaque size, apoptosis index and MRI signal, as previously described. 3, 5 Results Proton density weighted, T1-w, and T2-w MRI images showed a differential contrast as illustrated in figure 1. Images of right carotid artery are shown with enough contrast for measurement of carotid lumen area and wall thickness of its branches at one-month intervals (panels in top row in figure 1 ). Gradient-echo and spin-echo MRI images showed distinct common carotid and vertebral artery vessels on T1 and T2 weighted images (panels in mid row in figure 1 ). The panels in the lower row represent the left common carotid artery thickening due to lesion and its intima-media thickness was measured (2.4-fold thick over normal), as illustrated on the image (right panel in lower row in figure 1) of left carotid artery. The power of the MRI is highlighted to distinguish the carotid wall thickness in a patient from that of normal carotid artery. anti-MMP-9, washed, and stained with avidinalkaline phosphatase (panel G), and stained with haematoxylin/eosin (panel H). The different staining methods visualised carotid artery tissue with distinct colours. However, quantitative image processing of these MR images with histological images showed good agreement in lumen area measurement (r 2 =0.9987; p=0.001), while MMP-9 metalloprotease enzyme digital images and histology digital images showed comparable lumen size (r 2 =0.9878; p=0.0001) ( figure 3) . Figure 2 shows the immunostaining of MMP-9 where increased colour intensities (asterisks in panel 4) mark high enzyme locations, enabling quick evaluation of focal disease burden. However, the quantitation was done in a subjective manner by comparing stain intensity at active enzyme locations compared with control negative enzyme locations by colour calibration in RGB mode by setting range 155 indicating 10 ng/mg MMP-9 enzyme protein colour. The carotid artery wall and plaque were delineated on both MMP-9 digital section and histopathology digital image as shown in Figure 3 . 
Discussion
The RAAS plays a significant role in the development of hypertensive cardiac and vascular remodelling. Recently, several genetic variants of its key components have been described in search of a potential risk factor which may be clinically relevant and useful in the evaluation of cardiovascular risk. [9] [10] [11] [12] [13] [14] 16, 17, [19] [20] [21] [22] [23] [24] [25] Some indicators such as blood pressure and aldosterone excretion have been reported as significant risk markers associated with the aldosterone synthase CYP11B2 gene. 24, 26 However, there is still debate whether the RAAS and its components are associated with cardiovascular risk and this remains to be established. 27 Therefore, we investigated the association between CYP11B2 gene polymorphisms and early signs of target carotid artery wall damage visible on MRI and measurable along with cytomorphic changes by histology, MMP and apoptosis immunostaining. The present data indicate that the CYP11B2 genotype may be associated with cross-sectional longitudinal carotid wall changes without relation to media-intima thickness in atherosclerosis. However, further studies of larger populations are needed to clarify whether the genetic CYP11B2 polymorphism is associated with carotid atherosclerosis in timewise progression. The present data also demonstrate that carotid atherosclerosis lesions and intima-media thickness may have different MMP and apoptosis correlates by immunostaining. The polymerase chain reaction-based immunoblotting of the CYP11B2 gene suggests that aldosteronism may be associated with the initial prevalence of carotid artery lesions. In higher overburden of carotid artery lesions, immunoblotting may not indicate the true association of aldosteronism with carotid artery lesions. However, these data do not support the hypothesis that a high reninsodium-profile carries an excessive risk of atherosclerosis lesions in primary hypertensive individuals with carotid plaques. 5, 25, 26 From a technical standpoint, the methods for MRI, immunoassay, genotyping and histology have been recently correlated with RAAS gene polymorphisms, but the sensitivity of each method appears controversial. In our laboratory, these methods are well-established and reported for the human carotid plaque to measure size and to determine plaque stability. MRI offers a noninvasive clinical method to visualise carotid vessel obstruction or lesions. 15 MMP-9, apoptosis, immunohistological and histology staining data further validate the MRI observations of plaque morphology. 8, 15, 28 Metalloproteinases are known to digest the collagen and elastin in the vessel wall to make it prone to rupture and weaken it for the development of an unstable plaque. Intracellular MMP-9 expression in atherosclerosis plaques has suggested multiform enzyme nature in artery remodelling, stiffness with multienzyme nature in T allele carrier T/T or C/T genotype patients experiencing stable angina and recent plaque rupture(s). 6, 7 The present major challenge is the visualisation and measurement of carotid artery wall changes by non-invasive imaging techniques with time series of disease progression. Another major challenge is the collection of cross-sectional endarterectomy specimens without damaging intracellular tissue cytomorphology. We noticed major temperature-dependent lipid phase changes, artifacts of TUNEL staining in preserved specimens and shrinkage in histology sections. These changes severely affect the measurements to establish a multivariate correlation and a prediction of association with the CYP11B2 gene polymorphism. The status of the CYP11B2 gene and its polymorphism are still not established and remain to be proven. 10 In the present study, the association of MRI, MMP-9 and apoptosis immunohistological data, and gene polymorphism was observed to possibly relate to carotid plaque stability.
The present study has limitations. In this preliminary work, patient data are limited and the frequencies of alleles and genotypes have not been tested for Hardy-Weinberg equilibrium. Another limitation is that MMP-9 zymography data have not been shown, which would demonstrate the quantitative nature of MMP-9 active enzyme in carotid artery tissue. We could, however, carry out logistic regression analysis if more subjects were available. Therefore, the main result of the study is the significant association of the -344T/C CYP11B2 gene polymorphism with carotid atherosclerotic plaque characteristics (plaque size by MRI, MMP-9 levels, apoptosis index).
Conclusion
The MRI-visible plaque features, MMP-9 localisation and apoptosis immunohistological data on carotid atherosclerosis lesions and CYP11B2 genotype polymorphism patterns may be associated.
